Speaker

David Anderson

Executive Director, Aclaris Therapeutics

David Anderson, Executive Director at Aclaris Therapeutics, spoke at 4th Covalent Drug Discovery & Development Summit (Boston, United States of America, 20–22 Oct 2026) in the session “Workshop B: Optimizing Translational Readiness in Covalent Programs Through Robust Integration of kinact/KI & Selectivity Data”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

4th Covalent Drug Discovery & Development Summit
20–22 Oct 2026Boston, United States of America
- WorkshopWorkshop B: Optimizing Translational Readiness in Covalent Programs Through Robust Integration of kinact/KI & Selectivity DataWith Weixue Wang

More speakers at 4th Covalent Drug Discovery & Development Summit

Sara Buhrlage
Associate Professor, Biological Chemistry & Molecular Pharmacology, Dana-Farber Cancer Institute
Antony Burton
Associate Director, Chemical Biology & Proteomics, Dunad Therapeutics
Jianwei (John) Che
Core Director, Dana-Farber Cancer Institute
Julian Dopstadt
Director, Eli Lilly
Jay Duffner
Director & Head of Discovery Biology, Frontier Medicines
Alex Federation
Co-Founder and Chief Executive Officer, Talus Bio

See all 20 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by David Anderson, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].